The current valuation score of Agios Pharmaceuticals Inc is 8.38, ranking 139 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.71, which is -210.29% below the recent high of 5.19 and -64.37% above the recent low of -7.74.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.